Stay informed with the latest updates for the inheritable blood disorders community. Industry New Prophylaxis Approval for REBINYN®Aug 3, 2022 Industry Sanofi Provides Fitusiran Trial Updates at ISTHJul 25, 2022 Industry Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…Jul 22, 2022 Industry Sanofi and Sobi® Report Progress with BIVV001 at International Congress Jul 20, 2022 Industry Bayer Announces Discontinuation of Kogenate® FSJun 2, 2022 Industry FDA Grants Breakthrough Status to BIVV001 Jun 1, 2022 Industry FDA Accepts Priority Review BLA for Hemophilia B Gene TherapyMay 24, 2022 Industry First Patient Dosed in Freeline’s Dose-Confirmation Trial for…Mar 25, 2022 Industry BioMarin Provides Update Including Next Steps for Investigational Gene…Jan 11, 2022 Industry Sigilon Announces a Priority Shift in Light of Clinical Trial SetbacksDec 17, 2021 Industry uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene…Dec 9, 2021 Industry Sigilon Reports Trial Updates for Investigational Hemophilia A Therapy Nov 29, 2021 Industry Spark Announces Multiyear Data Update for Investigational Gene TherapyNov 19, 2021 NBDF & Community NHF Applauds Implementation of the Hemophilia SNF Access ActOct 1, 2021 Medical Prophylaxis Indication Restored for BeneFIX® Sep 14, 2021 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page